변리사스쿨 2024년 10월 시간표

변리사스쿨 로고 이미지

카카오톡 문의하기
약력
  • 서울의대 석사 졸업 (종양생물학 전공)
    서울의대 의학박사학위 취득(암 면역학, 병리학 전공)

경력
  • 現 변리사 스쿨 생물 전문 교수
    現 메가엠디 상위권편입 생물 전문 교수
    現 메가엠디 일반생물학 PEET 전문 교수
    現 메가엠디 서류/면접 MDP 전문 교수
    └ 서류면접 4년 연속 1위 및 최다 수강생 보유
    現 메가엠디 종합반 일반생물학 전문 교수
    └ 종합반 생물평가 4년 연속 1위
    現 서울대학교 총동창회 이사
    前 PMS 의치전원 생물/면접 전문 교수

    암 연구재단 (2010): 최우수 연구상
    미국 암 연구학회 (100주년): 상위논문으로 선정

    [SCI 논문 (외국의학논문)]
    [제 1저자]
    1.The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131.
    2. Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination.
    3. Antitumor effects of combined GM-CSF and MIP3 alpha plasmid DNA.
    4. CpG oligodeoxynucleotides enhance the activities of CD8+ cytotoxic T-lymphocytes generated by combined hMUC1 vaccination and hNIS radioiodine gene therapy.
    5. In Vivo Scintigraphic Imaging of Antitumor Effects by Combined Radioiodine Therapy and Human Sodium Iodide Symporter Gene Immunotherapy.
    6. Human Sodium/Iodide Symporter (hNIS)-Mediated Radioiodine Gene Therapy Enhances the Killing Activities of Cytotoxic T Cells in a Mouse Tumor Model.
    7. Synergistic tumoricidal effect of combined hMUC1 vaccination and hNIS radioiodine gene therapy.
    8. MIDGE/hNIS vaccination generates antigen-associated CD8+IFN-gamma+ T cells and enhances protective antitumor immunity.
    9. In vivo bioluminescence visualization of antitumor effects by human MUC1 vaccination.
    10. Human sodium iodide symporter gene adjunctive radiotherapy to enhance the preventive effect of hMUC1 DNA vaccine.
    11. Immune response to firefly luciferase as a naked DNA.

    [공동저자]
    1. Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway.
    2. A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene.
    3. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1. Molecular Cancer.
    4. Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression.
    5. Over-expression of adenine nucleotide translocase 1 (ANT1) induces apoptosis and tumor regression in vivo.
    6. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo.
    7. In vivo monitoring of DNA vaccine gene expression using firefly luciferase as a naked DNA.